Abstract
Tetrabenazine (TBZ) depletes presynaptic dopamine in the CNS. It has been found to be beneficial in hyperkinetic movement disorders without carrying the extrapyramidal side effects that are characteristic of neuroleptics.
| Lingua originale | English |
|---|---|
| pagine (da-a) | 2883-2896 |
| Numero di pagine | 14 |
| Rivista | Expert Opinion on Pharmacotherapy |
| Volume | 10 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2009 |
Keywords
- Adrenergic Uptake Inhibitors
- Animals
- Drug Interactions
- Humans
- Models, Animal
- Nervous System Diseases
- Randomized Controlled Trials as Topic
- Tetrabenazine